ABSTRACT
Group-specific component (Gc) variants of vitamin D binding protein differ in their affinity for vitamin D metabolites that modulate antimycobacterial immunity. We conducted studies to determine whether Gc genotype associates with susceptibility to tuberculosis (TB). The following subjects were recruited into case-control studies: in the UK, 123 adult TB patients and 140 controls, all of Gujarati Asian ethnic origin; in Brazil, 130 adult TB patients and 78 controls; and in South Africa, 281 children with TB and 182 controls. Gc genotypes were determined and their frequency was compared between cases versus controls. Serum 25-hydroxyvitamin D (25(OH)D) concentrations were obtained retrospectively for 139 Gujarati Asians, and case-control analysis was stratified by vitamin D status. Interferon (IFN)-gamma release assays were also performed on 36 Gujarati Asian TB contacts. The Gc2/2 genotype was strongly associated with susceptibility to active TB in Gujarati Asians, compared with Gc1/1 genotype (OR 2.81, 95% CI 1.19-6.66; p = 0.009). This association was preserved if serum 25(OH)D was <20 nmol.L(-1) (p = 0.01) but not if serum 25(OH)D was > or =20 nmol.L(-1) (p = 0.36). Carriage of the Gc2 allele was associated with increased PPD of tuberculin-stimulated IFN-gamma release in Gujarati Asian TB contacts (p = 0.02). No association between Gc genotype and susceptibility to TB was observed in other ethnic groups studied.
Subject(s)
Tuberculosis/genetics , Vitamin D-Binding Protein/blood , Vitamin D-Binding Protein/genetics , Vitamin D/blood , Adult , Alleles , Asia/ethnology , Brazil , Case-Control Studies , Chi-Square Distribution , Child, Preschool , Female , Gene Frequency , Genetic Predisposition to Disease , Genotype , Haplotypes , Humans , Interferon-gamma/blood , Logistic Models , Male , Middle Aged , Polymerase Chain Reaction , South Africa , Tuberculosis/ethnology , United KingdomABSTRACT
In the present study we investigated the flagellin-specific serum (IgG) and fecal (IgA) antibody responses elicited in BALB/c mice immunized with isogenic mutant derivatives of the attenuated Salmonella enterica serovar Typhimurium (S. Typhimurium) SL3261 strain expressing phase 1 (FliCi), phase 2 (FljB), or no endogenous flagellin. The data reported here indicate that mice orally immunized with recombinant S. Typhimurium strains do not mount significant systemic or secreted antibody responses to FliCi, FljB or heterologous B-cell epitopes genetically fused to FliCi. These findings are particularly relevant for those interested in the use of flagellins as molecular carriers of heterologous antigens vectored by attenuated S. Typhimurium strains.
Subject(s)
Antibodies, Bacterial/blood , Flagellin/immunology , Salmonella Vaccines/immunology , Salmonella typhimurium/immunology , Administration, Oral , Animals , Bacterial Vaccines/immunology , Mice , Mice, Inbred BALB C , Salmonella Vaccines/administration & dosage , Vaccines, Attenuated/immunologyABSTRACT
In the present study we investigated the flagellin-specific serum (IgG) and fecal (IgA) antibody responses elicited in BALB/c mice immunized with isogenic mutant derivatives of the attenuated Salmonella enterica serovar Typhimurium (S. Typhimurium) SL3261 strain expressing phase 1 (FliCi), phase 2 (FljB), or no endogenous flagellin. The data reported here indicate that mice orally immunized with recombinant S. Typhimurium strains do not mount significant systemic or secreted antibody responses to FliCi, FljB or heterologous B-cell epitopes genetically fused to FliCi. These findings are particularly relevant for those interested in the use of flagellins as molecular carriers of heterologous antigens vectored by attenuated S. Typhimurium strains.
Subject(s)
Animals , Mice , Antibodies, Bacterial/blood , Flagellin/immunology , Salmonella Vaccines/immunology , Salmonella typhimurium/immunology , Administration, Oral , Bacterial Vaccines/immunology , Mice, Inbred BALB C , Salmonella Vaccines/administration & dosage , Vaccines, Attenuated/immunologyABSTRACT
Salmonella fIagellin has been repeatedly used as a carrier for heterologous peptide epitopes either as a parenterally delivered purified antigen or as a parenterally/orally-administered, flagellated, live, attenuated vaccine. Nonetheless, the ability to induce specific antibody responses against the flagellin moiety, fused or not with heterologous peptide, has not usually been reported in mice orally inoculated with a live, attenuated, flagellated Salmonella strain. In this work we evaluated the immunogenicity of flagellin in mice following oral inoculation with an aroA Salmonella enterica serovar Dublin SL5929 strain, which expressed plasmid-encoded recombinant hybrid flagellin fused to the CTP3 epitope (amino acids 50-64) of cholera toxin B-subunit. In contrast to parenterally immunized mice, no significant CTP3- or flagellin-specific antibody responses either in sera (IgG) or feces (IgA) were detected following repeated oral delivery of the recombinant Salmonella strain to C57BL/6 mice. Similarly, flagellin-specific antibody responses were also not detected in mice immunized with strain SL5930, which expressed a nonhybrid flagellin. The lack of flagellin-specific antibody responses was not associated with deficient Peyer patch colonization or spleen invasion. Moreover, stabilization of the flagellin-coding gene by integration into the host chromosome did not significantly improve flagellin-specific antibody responses following administration by the oral route. Taken together, these results suggest that flagellin does not represent an efficient peptide carrier for activation of antibody responses in mice orally immunized with live, attenuated Salmonella strains.
Subject(s)
Antibodies, Bacterial/analysis , Bacterial Vaccines/immunology , Cholera Toxin/immunology , Flagellin/immunology , Peptide Fragments/immunology , Salmonella enterica/immunology , Administration, Oral , Animals , Bacterial Vaccines/administration & dosage , Cholera Toxin/genetics , Digestive System/microbiology , Drug Carriers/administration & dosage , Feces , Female , Flagellin/genetics , Immunoglobulin A/analysis , Immunoglobulin G/blood , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Peptide Fragments/genetics , Plasmids , Salmonella enterica/genetics , Vaccines, Attenuated/administration & dosage , Vaccines, Attenuated/immunology , Vaccines, Synthetic/administration & dosage , Vaccines, Synthetic/immunologyABSTRACT
A nonapeptide from IL-1beta has been reported to be an immunostimulant and adjuvant. To investigate the possibility of enhancing the immunogenicity of recombinant antigens delivered by live-attenuated Salmonella strains, we inserted an oligonucleotide coding for the nonapeptide from murine IL-1beta into the genes of three model proteins: LamB, MalE, and flagellin. The hybrid proteins were expressed and delivered in vivo by Salmonella aroA strains, and serum antibody responses were analyzed. The results showed that the nonapeptide induced an increase in the immune response against Salmonella-delivered flagellin, measured on day 28 post-immunization. However, the adjuvant effect was lost by day 42. In no case was an adjuvant effect detected for Salmonella-delivered LamB or MalE. Thus, by comparing the immune responses raised by purified MalE with and without the peptide, we investigated whether the insertion of the peptide affected the immunogenicity of the protein itself. Also in this case, a modest adjuvant effect was shown only after primary immunization and when very low doses of antigen were used. In conclusion, the immunomodulatory properties of the IL-1beta peptide can also be detected when it is delivered in vivo by Salmonella; however, the effect is modest and antigen-dependent.
Subject(s)
Adjuvants, Immunologic/pharmacology , Carrier Proteins/immunology , Flagellin/immunology , Interleukin-1/pharmacology , Peptide Fragments/pharmacology , Salmonella/genetics , Animals , Female , Immunoglobulin G/blood , Maltose-Binding Proteins , Mice , Mice, Inbred BALB C , Mice, Inbred C3H , RabbitsABSTRACT
Neste artigo é apresentado um novo dispositivo para aferição do pontecial aplicado entre os eletrodos de um tubo radiográfico. Ele opera utilizando um sensor de raios-X à base de silício e o sistema eletrônico empregado deriva de um instrumento detector de cintilação desenvolvido anteriormente. No trabalho são apresentados, também, os resultados da calibração e dos testes realizados com um equipamento convencional de radiodiagnóstico, com um mamógrafo e com um aparelho de raios-X odontológico. Além disso, uma ampliação do circuito eletrônico tambem permite que o dispositivo possa atuar como dosímetro. São discutidas as vantagens desse novo dispositivo numa comparação com outros instrumentos de aferição de kVp, incluindo o detector de cintilaçao proposto anteriormente.
Subject(s)
Dosimetry , Quality of Health Care , Radiography , Quality ControlABSTRACT
Oligonucleotides coding for linear epitopes of the fimbrial colonization factor antigen I (CFA/I) of enterotoxigenic Escherichia coli (ETEC) were cloned and expressed in a deleted form of the Salmonella muenchen flagellin fliC (H1-d) gene. Four synthetic oligonucleotide pairs coding for regions corresponding to amino acids 1 to 15 (region I), amino acids 11 to 25 (region II), amino acids 32 to 45 (region III) and amino acids 88 to 102 (region IV) were synthesized and cloned in the Salmonella flagellin-coding gene. All four hybrid flagellins were exported to the bacterial surface where they produced flagella, but only three constructs were fully motile. Sera recovered from mice immunized with intraperitoneal injections of purified flagella containing region II (FlaII) or region IV (FlaIV) showed high titres against dissociated solid-phase-bound CFA/I subunits. Hybrid flagellins containing region I (FlaI) or region III (FlaIII) elicited a weak immune response as measured in enzyme-linked immunosorbent assay (ELISA) with dissociated CFA/I subunits. None of the sera prepared with purified hybrid flagella were able to agglutinate or inhibit haemagglutination promoted by CFA/I-positive strains. Moreover, inhibition ELISA tests indicated that antisera directed against region I, II, III or IV cloned in flagellin were not able to recognize surface-exposed regions on the intact CFA/I fimbriae.
Subject(s)
Bacterial Proteins/immunology , Escherichia coli/immunology , Fimbriae Proteins , Fimbriae, Bacterial/immunology , Flagellin/immunology , Amino Acid Sequence , Animals , Bacterial Proteins/biosynthesis , Bacterial Proteins/chemistry , Base Sequence , Cloning, Molecular , Enzyme-Linked Immunosorbent Assay , Epitopes/biosynthesis , Epitopes/chemistry , Epitopes/immunology , Escherichia coli/genetics , Escherichia coli/pathogenicity , Flagellin/chemistry , Flagellin/genetics , Hemagglutination Inhibition Tests , Hemagglutination Tests , Mice , Molecular Sequence Data , Oligodeoxyribonucleotides , Recombinant Proteins/biosynthesis , Recombinant Proteins/chemistry , Restriction Mapping , Salmonella/geneticsABSTRACT
The promoter of the Escherichia coli gene nirB is induced by both the presence of nitrite in the environment and by low oxygen tensions. It has been used to direct the high-level expression of heterologous proteins by E. coli strains in fermentors, and attenuated Salmonella strains expressing foreign proteins under nirB promoter (pnir) control have efficiently induced an immune response against these proteins. The genes encoding two different E. coli envelope proteins, the outer membrane protein LamB and the periplasmic protein MalE, were placed under pnir control on pBR322 derivatives, and both proteins were expressed at high levels during anaerobic growth. Our results showed that the expression level of MalE was influenced by the distance between the pnir promoter and the Shine-Dalgarno sequence: the highest levels were obtained by the longest constructs made; pnir directed a 4-fold increase in the level of MalE expression relative to the level reached by the previously described ptac-MalE expression vector. The best pnir construct produced 25 mg of MalE protein per 5 x 10(11) bacteria, which represents over 20% of total cell protein. Overexpression of MalE was well tolerated by E. coli, even under strict anaerobic conditions; for LamB, optimal induction was achieved under partial anaerobiosis. A MalE-HIV1 hybrid protein (33 residues from the V3 loop of HIV1 gp160 inserted into site 133 of MalE) was also overexpressed at a similar yield under pnir control, without apparent degradation of the hybrid protein. Moreover, when expressed in attenuated aroA S. typhimurium strain SL3261, the plasmids carrying malE and malE-HIV genes were stable in vitro and in vivo.
Subject(s)
Antigens, Bacterial/genetics , Escherichia coli/genetics , Genes, Bacterial/genetics , Promoter Regions, Genetic/genetics , Salmonella typhimurium/genetics , Anaerobiosis , Bacterial Outer Membrane Proteins/analysis , Bacterial Outer Membrane Proteins/genetics , Bacterial Proteins/analysis , Bacterial Proteins/genetics , Electrophoresis, Polyacrylamide Gel , Escherichia coli/immunology , Gene Expression Regulation, Bacterial , In Vitro Techniques , Plasmids , Salmonella typhimurium/immunologyABSTRACT
Each of the two mutants isolated from a fliC (= hag, flagellin-deficient) Escherichia coli strain made motile by a plasmid carrying the fliC gene of Salmonella muenchen by selection for motility in the presence of anti-d (Salmonella flagellar antigen) serum had both lost and gained one or more subfactors of the wild-type antigen. In one mutant codon 246 was GAC (alanine) instead of GCC (asparagine); the other had a deletion of 105 base pairs, explicable by a 10bp direct repeat, starting at bases 782 and 887. The in vitro removal of a 48bp EcoRV(631)/EcoRV(679) fragment produced plasmid pLS408, which was found to lack a subfactor of wild-type antigen d but able to confer motility on flagellin-negative Salmonella sp. (and used for insertion of epitope-specifying oligonucleotides at its EcoRV site). Immunoblotting with absorbed and unabsorbed sera from rabbits immunized with E. coli with wild-type or mutated antigen d showed that the fusion proteins specified by lambda gt11 with the N-terminal part of gene lacZ joined to a restriction fragment coding for residues 145-391 of flagellin gave the same pattern of parent-specific and mutant-specific reactions as the flagellate bacteria. Four out of five similarly selected mutants had the same 105 bp deletion as the first-isolated mutant; the fifth had a 72 bp deletion made possible by a 7-base pair direct repeat, starting at positions 649 and 721. All these changes in serological character without loss of function affected segment IV, specifying residues 182 to 308 of the total of 505, where there is little homology between different flagellar-antigen alleles.